CDH11

(redirected from CAD11)

CDH11

A gene on chromosome 16q21 that encodes a calcium-dependent cell–cell adhesion glycoprotein (cadherin), which is involved in regulating cell–cell adhesions, mobility and proliferation of epithelial cells. CDH11 is a so-called type-II (atypical) cadherin—which lacks a HAV cell adhesion recognition sequence specific to type-I cadherins—and is expressed in osteoblastic cell lines. It is upregulated during differentiation, suggesting a role during in bone development and maintenance.

Molecular pathology
Defects in CDH11 commonly occur in aneurysmal bone cysts and consist of a translocation t(16;17)(q22;p13) with USP6.
Mentioned in ?
References in periodicals archive ?
is the investment adviser to the First Investors family of funds, which had nearly CAD11 billion in total assets under management as of December 31, 2015.
18 October 2013 - UK scientific digital camera maker Andor Technology plc (LON:AND) said today it had acquired Spectral Applied Research Inc, a Canadian manufacturer of optical systems for cell biology research, for CAD11.
According to the contract, Petrominerales shareholders will receive CAD11 cash for each Petrominerales common share held, for a total value of around CAD935m in cash and one common share of a newly formed exploration and production company and the assumption of net debt estimated at CAD640m, including convertible bonds.
The amount allocated for Vioxx users in Canada will be between CAD11.
77bn for the second quarter of 2011, compared to CAD11.
As a result, the company is entitled to receive a termination fee of CAD11.
The stock offering will be carried out on a "bought deal" basis and its size could increase by 1,433,121 shares for CAD11.
The company has increased the purchase price by CAD11 per cubic metre to CAD459 per cubic metre effective June 02, 2010.
The net amount at risk has declined by 54 percent over the year to CAD11.
Orko also mentioned today, that its agreement with First Majestic involves a termination fee of CAD11.